Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Moodys
Merck

Last Updated: June 28, 2022

Drug Price Trends for LAMIVUDINE


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for LAMIVUDINE

Average Pharmacy Cost for LAMIVUDINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
LAMIVUDINE 300 MG TABLET 50268-0460-11 1.75707 EACH 2021-06-23
LAMIVUDINE 300 MG TABLET 50268-0460-13 1.75707 EACH 2021-06-23
LAMIVUDINE 300 MG TABLET 33342-0002-07 1.75707 EACH 2021-06-23
LAMIVUDINE 300 MG TABLET 31722-0754-30 1.75707 EACH 2021-06-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Subscribe to access the full database, or Sign up for a Free Trial

Best Wholesale Price for LAMIVUDINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CIMDUO 300MG/300MG Mylan Specialty L.P. 49502-0450-93 30 702.43 23.41433 EACH 2022-01-15 - 2027-01-14 Big4
CIMDUO 300MG/300MG Mylan Specialty L.P. 49502-0450-93 30 777.10 25.90333 EACH 2022-01-15 - 2027-01-14 FSS
EPIVIR 150MG TABLETS ViiV HealthCare Company 49702-0203-18 60 409.48 6.82467 EACH 2022-01-01 - 2026-08-14 FSS
EPIVIR 300MG TAB ViiV HealthCare Company 49702-0204-13 30 304.74 10.15800 EACH 2021-08-15 - 2026-08-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or Sign up for a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group